The FDA announced on 2021-10-27 that Teva Pharmaceuticals USA voluntarily recalled Cartia XT capsules due to incorrect expiration dates on the labeling. The recall affects 32,316 bottles distributed nationwide.
How to tell if you have it
- Brand: Teva
- Product: Cartia XT Capsules (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg
- NDC: 62037-597-90
- Lot #: 100023805
- Labelled Exp. Date: 05/2023
- Quantity: 90 capsules per bottle
The hazard
The recall is classified as Class II due to the hazard of incorrect expiration dates on the product labeling.
Context
GovInfoNow's records show Teva Pharmaceuticals USA has 97 other recalls on record since 2013-10-11. Other recent recalls include Teva Doxylamine Succinate Tablets Recall (2022-01-18), Teva Tretinoin Capsules 10mg Recall (2022-01-10), and Teva Mimvey Tablets Recall (2022-01-07). Other recent recalls of similar products include Teva Isotretinoin Capsules 30mg Recall (2026-01-12), Kirkman Lidocaine Cream Recall (2026-02-18), and OurPharma Fentanyl Injection Recall (2026-09-03).